Gordon Freckleton

Gordon Freckleton is currently an Associate Scientific Director in the separations method development group at Bristol Myers Squibb. He has over 15 years of experience in CE focusing mainly on CE-SDS and iCIEF method development and testing (with a little LabChip, N-glycan, and CZE on the side) at ImClone/Eli Lilly and Celgene/BMS. He has degrees in biology and molecular biology, and performed DNA sequencing for a biotech startup and protein sequencing for Sloan-Kettering in between.